Alnylam Pharmaceuticals

Principal Statistical Programmer

Alnylam Pharmaceuticals  •  $181k - $205k/yr  •  United States (Remote)  •  3 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

NOTICE OF FILING AN APPLICATION FOR PERMANENT EMPLOYMENT
CERTIFICATION

JOB TITLE: Principal Statistical Programmer 

JOB DUTIES: Write SAS programs that produce or validate tables, listings, figures and analysis datasets,
in support of clinical studies or complex integrated analyses for submission. Develop and follow good
programming practices, including adequately documenting SAS code. Perform, plan and coordinate project
work to ensure timely, quality delivery across multiple projects. Use, modify, and maintain existing SAS
code. Write specifications to describe programming needs. Create and validate global macros or systems
that streamline repetitive operations to increase programming efficiency. Keep abreast of current and new
statistical programming techniques and other applicable technical advancements while assisting in their
implementation. Provide input into, or lead general standardization efforts (e.g., CRFs, query checks,
standard statistical programs, data presentations). Assist or lead efforts to develop programming processes
consistent with industry best practices. Review DMP, eCRF specs, and other clinical data management
documents. Review statistical analysis plans and other related documents. Partner with or oversee CROs or
programming vendors to perform any of the above tasks. Hybrid in-office/remote position.

MINIMUM EDUCATION AND EXPERIENCE REQUIREMENTS: Bachelor’s degree in
Engineering (any), Information Technology, Information Systems, Computer Science or related field of
study and eight (8) years of experience in the job offered or related occupation in which the required
experience was gained. Must have demonstrated experience with: Provide input into and/or lead
standardization initiatives related to case report forms (CRFs), query checks, statistical programming
standards, and data presentation formats for Clinical trial reporting; review Data Management Plans
(DMPs), electronic Case Report Form (eCRF) specifications, and other clinical data management
documentation for accuracy and compliance; review Statistical Analysis Plans (SAPs) and related clinical
study documents to ensure alignment with study objectives and regulatory requirements; develop, validate,
and maintain SAS programs to generate Safety and Efficacy tables, listings, figures (TLFs), and analysis
datasets for clinical trial reporting; modify, enhance, and maintain existing SAS code to support ongoing
clinical programming activities and improve efficiency; prepare technical programming specifications
documenting programming requirements, data derivations, and validation procedures; design, develop,
validate, and maintain reusable global macros and automated systems to streamline repetitive programming
tasks and improve operational efficiency; utilize SAS to analyze and report clinical trial data for regulatory
submissions and internal review purposes; review and develop technical programming specifications and
SAS programs in accordance with regulatory and industry standards; apply CDISC standards, including
SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model), in the preparation and validation
of clinical datasets; create eSub package for Clinical trial reporting for FDA submission; apply statistical
methodologies and programming techniques to support the analysis, interpretation, and reporting of clinical
trial data; SAS Macro, SAS/SQL, SAS/GRAPH, and SAS/STAT.

OTHER: Employer: Alnylam US, Inc.

Job location: 675 W Kendall Street, Cambridge, MA 02142. Hybrid in-office/remote
position.

40 hours/week; $180,687.50 - $204,700.00/year (view contact information below)

If offered employment, must have legal right to work in U.S. EOE.

This notice is being posted as a result of the filing for a permanent resident labor certification application
for this job opportunity. Any person may provide documentary evidence bearing on the application to:

U.S. Department of Labor
 
2
Employment and Training Administration

Office of Foreign Labor Certification

200 Constitution Avenue NW, Room N-5311

Washington, DC 20210

CONTACT: To apply, submit a resume to
https://jobs.alnylam.com/careers-start=0&pid=893380660936&sort_by=hot, OR submit a resume to
https://jobquest.dcs.eol.mass.gov/jobquest/LandingPage.aspx OR mail resume to: Alnylam US, Inc., Attn:
HR, 675 West Kendall Street, Cambridge, MA 02142.
Alnylam Pharmaceuticals

About Alnylam Pharmaceuticals

SILENCE DISEASE. AMPLIFY LIFE.™

Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.

Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.

We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).

We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.

See our social media community guidelines: https://bit.ly/2FcRhJy.

Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Fraudulent Recruitment Activity

Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."

Industry
Biotech & Life Sciences
Company Size
1,001-5,000 employees
Headquarters
Cambridge, Massachusetts
Year Founded
2002
Social Media